Is it safe to let a patient with blood glucose in the 400‑540 mg/dL range (asymptomatic, not in diabetic ketoacidosis) continue sleeping and recheck in the morning, given his regimen of 48 U of 70/30 (70% NPH, 30% regular insulin) in the morning, 25 U at night, and sliding‑scale insulin lispro (Humalog)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Can You Let Him Sleep? Yes, But Check His Blood Glucose First

You should check his blood glucose now before letting him sleep, and if it remains >400 mg/dL, administer correctional insulin (Humalog) per sliding scale, then recheck in 2-4 hours rather than waiting until morning. While he is asymptomatic and not in DKA, sustained hyperglycemia >400 mg/dL overnight carries risks that outweigh the inconvenience of a glucose check and possible intervention.

Why You Need to Act Now

The patient's glucose has been dangerously elevated (404 mg/dL post-dinner, 540s last night), and sliding scale insulin alone is inadequate for managing his diabetes 1, 2. Current guidelines explicitly condemn using sliding scale insulin as the sole regimen for patients with established diabetes on home insulin 1. His home regimen of 70/30 insulin indicates he has significant insulin requirements, yet he's been without his scheduled basal insulin for days—this is the root problem.

The Immediate Overnight Plan:

  • Check his blood glucose now (don't wait until morning)
  • If ≥400 mg/dL: Give correctional Humalog per your sliding scale protocol
  • Recheck in 2-4 hours to ensure downward trend and rule out continued rise
  • If glucose remains >300 mg/dL on recheck: Consider giving a small dose of basal insulin (0.1-0.15 units/kg) tonight to prevent further escalation 2

Why Not Just Wait Until Morning?

Nocturnal Hyperglycemia Risks:

While he's asymptomatic now, prolonged severe hyperglycemia (>400 mg/dL) can progress to hyperosmolar hyperglycemic state (HHS), particularly in patients with type 2 diabetes 3. Unlike DKA, HHS develops insidiously and has mortality rates up to 20% 3. The fact that he was 540s last night and is now 400s suggests inadequate glycemic control that could worsen overnight without intervention.

The Sliding Scale Trap:

You're caught in a common pitfall: using sliding scale insulin reactively treats hyperglycemia after it occurs but doesn't prevent it 1. Guidelines from 2022 are clear that patients on home insulin should continue scheduled insulin therapy (modified for hospital conditions), not be switched to sliding scale alone 2.

What Went Wrong and How to Fix It

The Core Problem:

His home regimen (48 units 70/30 AM + 25 units PM = ~73 total daily units) provides both basal and prandial coverage. Premixed 70/30 insulin is explicitly not recommended in hospitals due to unacceptably high hypoglycemia rates 1, but the solution isn't to stop all scheduled insulin—it's to convert to a safer basal-bolus or basal-plus regimen.

Tomorrow's Plan (Don't Wait):

Calculate his total daily dose (TDD):

  • Home TDD = ~73 units
  • Reduce by 20% for hospitalization = ~58 units 2
  • Split: 50% basal (29 units) + 50% prandial (29 units divided before meals) 1

Implement basal-plus approach 1, 2:

  • Basal insulin: Give 29 units of long-acting insulin (glargine or detemir) once daily
  • Correctional insulin: Continue Humalog sliding scale before meals
  • This prevents the dangerous glucose excursions you're seeing while minimizing hypoglycemia risk

Critical Caveats

Don't Overcorrect Tonight:

  • If you give correctional insulin now, don't stack doses—wait 4 hours minimum before redosing
  • His glucose of 180-200 at home suggests his baseline control is poor; don't aim for normal glucose overnight (target 140-180 mg/dL per guidelines) 2

Morning Action Items:

  1. Discontinue sliding scale as sole therapy 1, 2
  2. Start scheduled basal insulin as calculated above
  3. Continue correctional Humalog before meals
  4. Monitor for hypoglycemia (basal-bolus increases risk 4-6 fold vs sliding scale, though severe hypoglycemia remains rare at 1-5%) 1

Why His Home Regimen Failed Him:

The 70/30 insulin he takes at home is problematic in hospitals because:

  • Fixed ratios don't adjust for variable food intake
  • Peak times don't align with hospital meal schedules
  • High hypoglycemia risk led to its discontinuation, but replacing it with nothing scheduled created this hyperglycemic crisis 1

Bottom Line

Don't let him sleep without checking his glucose and addressing levels >400 mg/dL. The asymptomatic nature is falsely reassuring—HHS develops slowly and he's already demonstrated glucose >500 mg/dL in the past 24 hours. Give correctional insulin now if needed, recheck in 2-4 hours, and implement a proper basal-plus regimen tomorrow morning. The goal isn't perfect control tonight; it's preventing further deterioration while you transition him to an appropriate inpatient insulin regimen 1, 2.

References

1
Guideline

management of diabetes and hyperglycaemia in the hospital.

The Lancet Diabetes and Endocrinology, 2021

Related Questions

How should I treat a patient with diabetic ketoacidosis (DKA) who has a serum bicarbonate of 8 mmol/L, blood glucose of 618 mg/dL, serum potassium of 4.4 mEq/L, and serum phosphate of 1.7 mg/dL?
In a patient with diabetic ketoacidosis and elevated carboxyhemoglobin, what is the appropriate management?
What is the appropriate initial management for a patient with diabetic ketoacidosis (glucose 427 mg/dL, serum sodium 127 mmol/L, CO₂ 18 mmol/L, anion gap 14, beta‑hydroxybutyrate 2.03 mmol/L)?
What is the recommended management of diabetic ketoacidosis?
How do I initiate long-term insulin therapy in a patient after resolution of diabetic ketoacidosis (DKA)?
Which sulfonylurea offers superior post‑prandial blood glucose control, glipizide or gliclazide?
What are the diagnostic criteria and steps for diagnosing vestibular neuritis?
What is the appropriate evaluation and management for a 78-year-old woman with a two-week history of dry cough and sore throat that worsen at night, improve during the day, and began after a resolved runny nose?
For a regular‑sized adult male (approximately 70–80 kg) who is neither thin nor obese, what constitutes a small correctional dose of rapid‑acting insulin when his blood glucose remains elevated?
Are there any FDA‑approved drugs that directly target claudin proteins, and what investigational agents are available for claudin‑positive cancers?
What does tislelizumab target?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.